Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality - Du, Lixin; Qin, Jiao; Wang, Dengchuan; Zhao, Yunhui; Xu, Ning; Wu, Chaowen (Frontiers in Cardiovascular Medicine, 2022)